Caradon Therapeutics, Inc. — Form D

Caradon Therapeutics, Inc. of ENCINITAS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-02-03. The offering totals $900K, of which $559K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-02-03
• Form: D
• Accession: 0002108983-26-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $900K
• Amount sold: $559K
• Remaining: $341K
• Investors: 7
• Date of first sale: 2026-01-08
• Revenue range: Decline to Disclose
• SEC file number: 021-572221

Issuer

• Name: Caradon Therapeutics, Inc.
• CIK: 0002108983
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2023
• Address: 1281 HYMETTUS AVE., ENCINITAS, CA, 92024
• Phone: (619) 990-0290

Officers, directors & promoters (2)

More

• CIK 2108983 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search